1Rojewski MT,Baldus C,Knauf W,et al.Dual effects of arsenic trioxide on acute promyelocytic leukemia myloid cell lines:induction of apoptosis and inhibition of proliferation.Br J Haematol,2002,116:555-563.
2Shin S,Sung BJ,Cho YS,et al.An anti-apoptotic protein human surviving is a direct inhibitor of caspase-3 and caspase-7.Biochemistry,2001,40:1117-1123.
3Maurizio A,Gianni J,Vermis I,et al.Tyrosine kinase inhibitor Sti571 potentiates the pharmacologic activity of retinoic zceel in acute promyelocytic leukemia cells:effects on the degradation of RARα and PML-RARα.Blood,2001,97:3234-3241.
4Quattrone A,Richel D.Quantitation of Bcl-2 oncogene in child lymphoma leukemia cell lines and primary leukemia B-cells by a hignly sensitive RT-PCR method.Haematol Method,1995,80:465-504.
5Chen GQ,Zhu J,Shi XG,et al.In Vitro studies on cellular and molecular mechanisms of arsenic trioxide in the treatment of acute promyelocytic leukemia As2O3 induces NB4 cell apoptosis is with downregulation of Bcl-2 expression and modulation of PML-RARα and RARα protein.Blood,1996,88:1052-1056.
6Dirks W,Schone SV.Expression and function of CD95 (Fas)leukemia-lymphoma tumor lines.Br J Haematol,1997,96:584-593.
